Nifedipine is a dihydropyridine L-type calcium channel blocker used to treat hypertension; its target gene (CACNA1S) and primary enzyme genes (CYP1A1 and CYP2A6) all had deleterious variants in our population. This evidence concerns the gene CYP2A6 and hypertensive disorder.